- Home
- AMLX vs EQBK Comparison
AMLX vs EQBK Comparison
Compare AMLX & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- EQBK
- Stock Information
- Founded
- AMLX 2014
- EQBK 2002
- Country
- AMLX United States
- EQBK United States
- Employees
- AMLX N/A
- EQBK N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- AMLX Health Care
- EQBK Finance
- Exchange
- AMLX Nasdaq
- EQBK Nasdaq
- Market Cap
- AMLX 749.9M
- EQBK 806.8M
- IPO Year
- AMLX 2022
- EQBK 2015
- Fundamental
- Price
- AMLX $14.45
- EQBK $41.64
- Analyst Decision
- AMLX Strong Buy
- EQBK Buy
- Analyst Count
- AMLX 7
- EQBK 6
- Target Price
- AMLX $16.86
- EQBK $47.80
- AVG Volume (30 Days)
- AMLX 1.9M
- EQBK 101.2K
- Earning Date
- AMLX 11-06-2025
- EQBK 10-14-2025
- Dividend Yield
- AMLX N/A
- EQBK 1.72%
- EPS Growth
- AMLX N/A
- EQBK N/A
- EPS
- AMLX N/A
- EQBK 1.00
- Revenue
- AMLX N/A
- EQBK $186,307,000.00
- Revenue This Year
- AMLX N/A
- EQBK $13.14
- Revenue Next Year
- AMLX N/A
- EQBK $39.83
- P/E Ratio
- AMLX N/A
- EQBK $41.72
- Revenue Growth
- AMLX N/A
- EQBK 18.09
- 52 Week Low
- AMLX $2.60
- EQBK $34.11
- 52 Week High
- AMLX $16.96
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- AMLX 55.78
- EQBK 54.85
- Support Level
- AMLX $13.88
- EQBK $40.15
- Resistance Level
- AMLX $16.96
- EQBK $41.79
- Average True Range (ATR)
- AMLX 0.99
- EQBK 1.29
- MACD
- AMLX -0.20
- EQBK 0.09
- Stochastic Oscillator
- AMLX 33.77
- EQBK 79.04
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.